Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.
CRISPR Causes More Genome Damage Than First ThoughtNews
Researchers have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
The patent broadly covers any siRNA molecule which targets conserved sequences within a virus or a gene.READ MORE
Scientists have studied mice with a single copy of the neuroD2 gene and found they had an impaired ability to form emotional memories and conditioned fear.READ MORE
The protein, known as RKIP, controls activity of kinases, a type of enzyme that acts as a key component in the biochemical signaling pathways responsible for determining almost all cellular activity.READ MORE
American Type Culture Collection will supply amaxa with cell lines to develop and optimize protocols using amaxa's Nucleofector® technology.READ MORE
Visitors to the show will have opportunity to see the features on Tecan's Freedom EVO® series of automated workstations, the HS 400 Pro fully automated hybridization station, the high sensitivity LS Reloaded Scanner and the flexible Safire2 microplate reader.READ MORE
Professor Burnstock, who played a major role in the development of CytRx's lead small molecule drug candidate arimoclomol, joins CytRx's Advisory Board.READ MORE